A Randomized, Placebo-Controlled, Double-Blind Pilot Study to Evaluate the Effect of GRF6021 on Intracellular Signaling Cascades in Blood Leukocytes and Postoperative Recovery Following Primary Hip or Knee Arthroplasty
Latest Information Update: 18 Mar 2024
At a glance
- Drugs GRF 6021 (Primary)
- Indications Postoperative complications
- Focus Pharmacodynamics; Proof of concept
- Sponsors Alkahest
Most Recent Events
- 19 May 2021 Status changed from active, no longer recruiting to completed.
- 16 Feb 2021 Planned End Date changed from 29 Jan 2021 to 6 Mar 2021.
- 16 Feb 2021 Status changed from recruiting to active, no longer recruiting.